Top

Published in:

22-09-2023

The TICE Pathway: Mechanisms and Potential Clinical Applications

Authors: Huimin Xu, Yiyang Xin, Jiaxin Wang, Zixin Liu, Yutong Cao, Weiguo Li, Yun Zhou, Yandong Wang, Peng Liu

Published in: Current Atherosclerosis Reports | Issue 10/2023

Abstract

Purpose of Review

Transintestinal cholesterol excretion (TICE) is a non-biliary pathway that excretes excess cholesterol from the body through feces. This article focuses on the research progress of the TICE pathway in the last few years, including the discovery process of the TICE pathway, its molecular mechanism, and potential clinical applications.

Recent Findings

Cholesterol homeostasis is vital for cardiovascular diseases, stroke, and neurodegenerative diseases. Beyond the cholesterol excretion via hepatobiliary pathway, TICE contributes significantly to reverse cholesterol transport ex vivo and in vivo. Nuclear receptors are ligand-activated transcription factors that regulate cholesterol metabolism. The farnesoid X receptor (FXR) and liver X receptor (LXR) activated, respectively, by oxysterols and bile acids promote intestinal cholesterol secretion through ABCG5/G8. Nutrient regulators and intestinal flora also modulate cholesterol secretion through the TICE pathway. TICE allows direct elimination of plasma cholesterol, which may provide an attractive therapeutic targets.

Summary

TICE pathway may provide a potential target to stimulate cholesterol elimination and reduce the risk of cardiovascular diseases.

Hu J, et al. Cellular cholesterol delivery, intracellular processing and utilization for biosynthesis of steroid hormones. Nutr Metab (Lond). 2010;7:47.PubMedCrossRef

Tabas I, García-Cardeña G, Owens GK. Recent insights into the cellular biology of atherosclerosis. J Cell Biol. 2015;209(1):13–22.PubMedPubMedCentralCrossRef

Glomset JA, Norum KR. The metabolic role of lecithin: cholesterol acyltransferase: perspectives form pathology. Adv Lipid Res. 1973;11:1–65.PubMedCrossRef

Garçon D, et al. Transintestinal cholesterol excretion in health and disease. Curr Atheroscler Rep. 2022;24(3):153–60.PubMedCrossRef

Stellaard, F. From dietary cholesterol to blood cholesterol, physiological lipid fluxes, and cholesterol homeostasis. Nutrients. 2022; 14(8).

de Boer JF, et al. Intestinal Farnesoid X receptor controls transintestinal cholesterol excretion in mice. Gastroenterology. 2017;152(5):1126-1138.e6.PubMedCrossRef

Tanaka Y, Kamisako T. Regulation of the expression of cholesterol transporters by lipid-lowering drugs ezetimibe and pemafibrate in rat liver and intestine. Biochim Biophys Acta Mol Basis Dis. 2021;1867(11):166215.PubMedCrossRef

•• Luo, J., H. Yang, B.L. Song. Mechanisms and regulation of cholesterol homeostasis. Nat Rev Mol Cell Biol, 2020. 21(4): 225–245. The study identified the key factors that govern the four pathways of cholesterol biosynthesis, uptake, export and esterification, and the main mechanisms by which they respond to different sterol levels.

Ouimet M, Barrett TJ, Fisher EA. HDL and reverse cholesterol transport. Circ Res. 2019;124(10):1505–18.PubMedPubMedCentralCrossRef

10.

Goedeke L, Fernández-Hernando C. Regulation of cholesterol homeostasis. Cell Mol Life Sci. 2012;69(6):915–30.PubMedCrossRef

11.

Brown MS, Goldstein JL. A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc Natl Acad Sci U S A. 1999;96(20):11041–8.PubMedPubMedCentralCrossRef

12.

Goldstein JL, DeBose-Boyd RA, Brown MS. Protein sensors for membrane sterols. Cell. 2006;124(1):35–46.PubMedCrossRef

13.

Sun LP, et al. Insig required for sterol-mediated inhibition of Scap/SREBP binding to COPII proteins in vitro. J Biol Chem. 2005;280(28):26483–90.PubMedCrossRef

14.

Sever N, et al. Accelerated degradation of HMG CoA reductase mediated by binding of insig-1 to its sterol-sensing domain. Mol Cell. 2003;11(1):25–33.PubMedCrossRef

15.

Goldstein JL, Rawson RB, Brown MS. Mutant mammalian cells as tools to delineate the sterol regulatory element-binding protein pathway for feedback regulation of lipid synthesis. Arch Biochem Biophys. 2002;397(2):139–48.PubMedCrossRef

16.

Altmann SW, et al. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science. 2004;303(5661):1201–4.PubMedCrossRef

17.

van Heek M, et al. Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function. Br J Pharmacol. 2001;134(2):409–17.PubMedPubMedCentralCrossRef

18.

Garcia-Calvo M, et al. The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1). Proc Natl Acad Sci U S A. 2005;102(23):8132–7.PubMedPubMedCentralCrossRef

19.

Altmann SW, et al. The identification of intestinal scavenger receptor class B, type I (SR-BI) by expression cloning and its role in cholesterol absorption. Biochim Biophys Acta. 2002;1580(1):77–93.PubMedCrossRef

20.

Li PS, et al. The clathrin adaptor Numb regulates intestinal cholesterol absorption through dynamic interaction with NPC1L1. Nat Med. 2014;20(1):80–6.PubMedCrossRef

21.

Johnson TA, Pfeffer SR. Ezetimibe-sensitive cholesterol uptake by NPC1L1 protein does not require endocytosis. Mol Biol Cell. 2016;27(11):1845–52.PubMedPubMedCentralCrossRef

22.

Jia L, Betters JL, Yu L. Niemann-pick C1-like 1 (NPC1L1) protein in intestinal and hepatic cholesterol transport. Annu Rev Physiol. 2011;73:239–59.PubMedPubMedCentralCrossRef

23.

Anderson RA, et al. Identification of a form of acyl-CoA:cholesterol acyltransferase specific to liver and intestine in nonhuman primates. J Biol Chem. 1998;273(41):26747–54.PubMedCrossRef

24.

Ingram MF, Shelness GS. Folding of the amino-terminal domain of apolipoprotein B initiates microsomal triglyceride transfer protein-dependent lipid transfer to nascent very low density lipoprotein. J Biol Chem. 1997;272(15):10279–86.PubMedCrossRef

25.

Berge KE, et al. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science. 2000;290(5497):1771–5.PubMedCrossRef

26.

Lee MH, et al. Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat Genet. 2001;27(1):79–83.PubMedPubMedCentralCrossRef

27.

Yu L, et al. Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. Proc Natl Acad Sci U S A. 2002;99(25):16237–42.PubMedPubMedCentralCrossRef

28.

Yu L, et al. Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J Clin Invest. 2002;110(5):671–80.PubMedPubMedCentralCrossRef

29.

Temel RE, et al. Intestinal cholesterol absorption is substantially reduced in mice deficient in both ABCA1 and ACAT2. J Lipid Res. 2005;46(11):2423–31.PubMedCrossRef

30.

Brunham LR, et al. Intestinal ABCA1 directly contributes to HDL biogenesis in vivo. J Clin Invest. 2006;116(4):1052–62.PubMedPubMedCentralCrossRef

31.

Tang W, et al. Niemann-Pick C1-like 1 is required for an LXR agonist to raise plasma HDL cholesterol in mice. Arterioscler Thromb Vasc Biol. 2008;28(3):448–54.PubMedCrossRef

32.

Doonan LM, Fisher EA, Brodsky JL. Can modulators of apolipoproteinB biogenesis serve as an alternate target for cholesterol-lowering drugs? Biochim Biophys Acta Mol Cell Biol Lipids. 2018;1863(7):762–71.PubMedCrossRef

33.

Yu L, et al. Expression of ABCG5 and ABCG8 is required for regulation of biliary cholesterol secretion. J Biol Chem. 2005;280(10):8742–7.PubMedCrossRef

34.

Cheng SH, Stanley MM. Secretion of cholesterol by intestinal mucosa in patients with complete common bile duct obstruction. Proc Soc Exp Biol Med. 1959;101(2):223–5.PubMedCrossRef

35.

van der Velde AE, et al. Direct intestinal cholesterol secretion contributes significantly to total fecal neutral sterol excretion in mice. Gastroenterology. 2007;133(3):967–75.PubMedCrossRef

36.

Smit JJ, et al. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell. 1993;75(3):451–62.PubMedCrossRef

37.

Brown JM, et al. Targeted depletion of hepatic ACAT2-driven cholesterol esterification reveals a non-biliary route for fecal neutral sterol loss. J Biol Chem. 2008;283(16):10522–34.PubMedPubMedCentralCrossRef

38.

Simmonds WJ, Hofmann AF, Theodor E. Absorption of cholesterol from a micellar solution: intestinal perfusion studies in man. J Clin Invest. 1967;46(5):874–90.PubMedPubMedCentralCrossRef

39.

Le May C, et al. Transintestinal cholesterol excretion is an active metabolic process modulated by PCSK9 and statin involving ABCB1. Arterioscler Thromb Vasc Biol. 2013;33(7):1484–93.PubMedCrossRef

40.

Jakulj L, et al. Transintestinal cholesterol transport is active in mice and humans and controls ezetimibe-induced fecal neutral sterol excretion. Cell Metab. 2016;24(6):783–94.PubMedCrossRef

41.

Moreau F, et al. In vivo evidence for transintestinal cholesterol efflux in patients with complete common bile duct obstruction. J Clin Lipidol. 2019;13(1):213-217.e1.PubMedCrossRef

42.

Hirata T, et al. Molecular mechanisms of subcellular localization of ABCG5 and ABCG8. Biosci Biotechnol Biochem. 2009;73(3):619–26.PubMedCrossRef

43.

Lu K, et al. Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively. Am J Hum Genet. 2001;69(2):278–90.PubMedPubMedCentralCrossRef

44.

Sabeva NS, Rouse EJ, Graf GA. Defects in the leptin axis reduce abundance of the ABCG5-ABCG8 sterol transporter in liver. J Biol Chem. 2007;282(31):22397–405.PubMedCrossRef

45.

Langheim S, et al. ABCG5 and ABCG8 require MDR2 for secretion of cholesterol into bile. J Lipid Res. 2005;46(8):1732–8.PubMedCrossRef

46.

Wang J, et al. Relative roles of ABCG5/ABCG8 in liver and intestine. J Lipid Res. 2015;56(2):319–30.PubMedPubMedCentralCrossRef

47.

Brown JM, Yu L. Opposing gatekeepers of apical sterol transport: Niemann-Pick C1-like 1 (NPC1L1) and ATP-binding cassette transporters G5 and G8 (ABCG5/ABCG8). Immunol Endocr Metab Agents Med Chem. 2009;9(1):18–29.PubMedPubMedCentralCrossRef

48.

Jakulj L, et al. Ezetimibe stimulates faecal neutral sterol excretion depending on abcg8 function in mice. FEBS Lett. 2010;584(16):3625–8.PubMedCrossRef

49.

van der Velde AE, et al. Regulation of direct transintestinal cholesterol excretion in mice. Am J Physiol Gastrointest Liver Physiol. 2008;295(1):G203-g208.PubMedCrossRef

50.

Inagaki T, et al. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab. 2005;2(4):217–25.PubMedCrossRef

51.

•• Blankestijn, M., et al., Induction of fecal cholesterol excretion is not effective for the treatment of hyperbilirubinemia in Gunn rats. Pediatr Res. 2021; 89(3): 510–517. Findings from this study suggest that OCA enhanced TICE by activating FXR.

52.

Janowski BA, et al. An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature. 1996;383(6602):728–31.PubMedCrossRef

53.

Plōsch T, et al. Increased hepatobiliary and fecal cholesterol excretion upon activation of the liver X receptor is independent of ABCA1. J Biol Chem. 2002;277(37):33870–7.PubMedCrossRef

54.

Repa JJ, et al. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science. 2000;289(5484):1524–9.PubMedCrossRef

55.

Kruit JK, et al. Increased fecal neutral sterol loss upon liver X receptor activation is independent of biliary sterol secretion in mice. Gastroenterology. 2005;128(1):147–56.PubMedCrossRef

56.

van der Veen JN, et al. Activation of the liver X receptor stimulates trans-intestinal excretion of plasma cholesterol. J Biol Chem. 2009;284(29):19211–9.PubMedPubMedCentralCrossRef

57.

• Lifsey HC et al. Stigmasterol stimulates transintestinal cholesterol excretion independent of liver X receptor activation in the small intestine. J NutrBiochem, 2020; 76: 108263. This study shows that LXR agonist T0901317 stimulates the TICE pathway by increasing the expression of ABCG5 and ABCG8 in the liver and duodenum.

58.

Grefhorst A, et al. Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles. J Biol Chem. 2002;277(37):34182–90.PubMedCrossRef

59.

van der Veen JN, et al. Reduced cholesterol absorption upon PPARdelta activation coincides with decreased intestinal expression of NPC1L1. J Lipid Res. 2005;46(3):526–34.PubMedCrossRef

60.

Oliver WR Jr, et al. A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport. Proc Natl Acad Sci U S A. 2001;98(9):5306–11.PubMedPubMedCentralCrossRef

61.

Sprecher DL, et al. Triglyceride:high-density lipoprotein cholesterol effects in healthy subjects administered a peroxisome proliferator activated receptor delta agonist. Arterioscler Thromb Vasc Biol. 2007;27(2):359–65.PubMedCrossRef

62.

Zhang DW, et al. Binding of proprotein convertase subtilisin/kexin type 9 to epidermal growth factor-like repeat A of low density lipoprotein receptor decreases receptor recycling and increases degradation. J Biol Chem. 2007;282(25):18602–12.PubMedCrossRef

63.

Sachdev V, et al. Novel role of a triglyceride-synthesizing enzyme: DGAT1 at the crossroad between triglyceride and cholesterol metabolism. Biochim Biophys Acta. 2016;1861(9 Pt A):1132–41.PubMedPubMedCentralCrossRef

64.

Marshall SM, et al. Acute sterol o-acyltransferase 2 (SOAT2) knockdown rapidly mobilizes hepatic cholesterol for fecal excretion. PLoS One. 2014;9(6):e98953.PubMedPubMedCentralCrossRef

65.

Sokolović M, et al. Unexpected effects of fasting on murine lipid homeostasis–transcriptomic and lipid profiling. J Hepatol. 2010;52(5):737–44.PubMedCrossRef

66.

Calpe-Berdiel L, Escolà-Gil JC, Blanco-Vaca F. New insights into the molecular actions of plant sterols and stanols in cholesterol metabolism. Atherosclerosis. 2009;203(1):18–31.PubMedCrossRef

67.

Brufau G, et al. A reappraisal of the mechanism by which plant sterols promote neutral sterol loss in mice. PLoS One. 2011;6(6):e21576.PubMedPubMedCentralCrossRef

68.

Koeth RA, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013;19(5):576–85.PubMedPubMedCentralCrossRef

69.

Wang Z, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472(7341):57–63.PubMedPubMedCentralCrossRef

70.

Sehayek E, Hazen SL. Cholesterol absorption from the intestine is a major determinant of reverse cholesterol transport from peripheral tissue macrophages. Arterioscler Thromb Vasc Biol. 2008;28(7):1296–7.PubMedPubMedCentralCrossRef

71.

Warrier M, et al. The TMAO-Generating enzyme flavin monooxygenase 3 is a central regulator of cholesterol balance. Cell Rep. 2015;10(3):326–38.PubMedPubMedCentralCrossRef

72.

Vrins CL, et al. Peroxisome proliferator-activated receptor delta activation leads to increased transintestinal cholesterol efflux. J Lipid Res. 2009;50(10):2046–54.PubMedPubMedCentralCrossRef

73.

Chandak PG, et al. Lack of acyl-CoA:diacylglycerol acyltransferase 1 reduces intestinal cholesterol absorption and attenuates atherosclerosis in apolipoprotein E knockout mice. Biochim Biophys Acta. 2011;1811(12):1011–20.PubMedPubMedCentralCrossRef

Title: The TICE Pathway: Mechanisms and Potential Clinical Applications
Authors: Huimin Xu
Yiyang Xin
Jiaxin Wang
Zixin Liu
Yutong Cao
Weiguo Li
Yun Zhou
Yandong Wang
Peng Liu
Publication date: 22-09-2023
Publisher: Springer US
Published in: Current Atherosclerosis Reports / Issue 10/2023
Print ISSN: 1523-3804
Electronic ISSN: 1534-6242
DOI: https://doi.org/10.1007/s11883-023-01147-6

PD Dr. Carsten W. Israel

Developed by: Springer Medizin

Start the cases

At a glance: The STEP trials

Obesity Clinical Trial Summary

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

ERS Congress 2024

Springer Medicine

The TICE Pathway: Mechanisms and Potential Clinical Applications

Abstract

Purpose of Review

Recent Findings

Summary

2024 ESC Congress

Noise pollution dangerous for heart health

Post-TAVI follow up: deploying virtual assistants

Antihypertensives: more effective at morning or night?

Low Lp(a) levels unlikely to increase the risk of diabetes

» View more highlights on the 2024 ESC Congress hub page

A quick guide to ECGs

At a glance: The STEP trials

ERS Congress 2024

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 10/2023

Fixed Combination for the Treatment of Dyslipidaemia

The Intersection Between COVID-19, Cardiovascular Disease, and Diet: a Review

Invasive Coronary Assessment in Myocardial Ischemia with No Obstructive Coronary Arteries

Mechanosensing and Mechanosignal Transduction in Atherosclerosis

The Greatly Under-Represented Role of Smooth Muscle Cells in Atherosclerosis

Effects of Omega-3 Fatty Acids on Flow-mediated Dilatation and Carotid Intima Media Thickness: A Meta-analysis

2024 ESC Congress

Noise pollution dangerous for heart health

Post-TAVI follow up: deploying virtual assistants

Antihypertensives: more effective at morning or night?

Low Lp(a) levels unlikely to increase the risk of diabetes

» View more highlights on the 2024 ESC Congress hub page

A quick guide to ECGs

At a glance: The STEP trials